š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a multicenter, randomized, open-label, Phase IV study to assess the...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-01-06
Trial ID
NCT01007448
Treatments Being Tested
The main objective is to determine the safety and tolerability of combinati...
Status
Completed
Location
Washington University School of Medicine
Start Date
2010-05
Trial ID
NCT01001143
Treatments Being Tested
Primary objective: To determine the Phase II doses and to evaluate the safe...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2003-04
Trial ID
NCT01116622
Treatments Being Tested
The researchers are doing this study to test the safety of combining bexaro...
Status
Recruiting
Location
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
Start Date
2022-03-16
Trial ID
NCT05296304
Treatments Being Tested
This study is designed to determine the recommended dose, safety, pharmacok...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2010-03
Trial ID
NCT01134341
Treatments Being Tested
The primary objective of this proof of mechanism pilot clinical trial is to...
Status
Completed
Location
Compass Research
Start Date
2014-08
Trial ID
NCT02061878
Treatments Being Tested
The purpose of this study is to determine the efficacy of the drug, HuMax-C...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2005-07
Trial ID
NCT00127881
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin and be...
Status
Completed
Location
Hackensack University Medical Center Cancer Center
Start Date
2005-11
Trial ID
NCT00255801
Treatments Being Tested
The goal of this clinical research study is to find the most effective dose...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-05
Trial ID
NCT00063076
Treatments Being Tested